Back to results
US 2008/0293801 A1Published application
Solid Amorphous Dispersions of An Mtp Inhibitor For Treatment of Obesity
AssigneePfizer Inc.
InventorsDwayne T. Friesen, Ravi M. Shanker
Life of this patent
Estimating the term…
Abstract
A composition comprises a solid amorphous dispersion comprising (S)—N-{2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl}-methyl-5-[4′-(trifluoromethyl)[1,1′-biphenyl]-2-carboxamido]-1H-indole-2-carboxamide and a polymer.
Claims16
A solid amorphous dispersion comprising a compound having Formula (I)
- and a polymer, wherein said compound is present in an amount of at least about 40 wt % of said solid amorphous dispersion.
A process for forming a solid amorphous dispersion comprising:
- (a) dissolving a compound and a polymer in a solvent to form a spray solution;
- (b) rapidly evaporating said solvent from said spray solution to form said solid amorphous dispersion;
- wherein said compound has Formula I
Dependencies are inferred from the claim text.